Concepedia

Mayuko Inagaki

MI

7

Publications

966

Citations

7

H-Index

2011

Active since

Affiliations

Portola Pharmaceuticals (United States)(Current)

Mayuko Inagaki is an author at Portola Pharmaceuticals (United States) specializing in pharmacotherapy, hematology, and thrombosis.

Top concepts

Publications per year

2011–2023

7

Publications

7

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

Genmin Lu, Francis DeGuzman, Stanley J. Hollenbach et al. · Nature Medicine · 2013 · 689 citations

, , +13

Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis

Greg Coffey, Francis DeGuzman, Mayuko Inagaki et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 116 citations

The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer

Greg Coffey, Andreas Betz, Francis DeGuzman et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 89 citations

Thienopyridines, but Not Elinogrel, Result in Off-Target Effects at the Vessel Wall That Contribute to Bleeding

Patrick André, Francis DeGuzman, Helena Haberstock-Debic et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 27 citations

PRT064445 but Not Recombinant Fviia Reverses Rivaroxaban Induced Anticoagulation As Measured by Reduction in Blood Loss in a Rabbit Liver Laceration Model

Stanley J. Hollenbach, Genmin Lu, Siusze Tan et al. · Blood · 2012 · 20 citations

Rows per page

1–5 of 7